Generation of tumor-specific cytotoxic T lymphocytesin vivoby combined treatment with inactivated tumor cells and recombinant interleukin-2
β Scribed by Mamoru Harada; Goro Matsuzaki; Yoshihiro Shinomiya; Shin Kurosawa; Osamu Ito; Tadao Okamoto; Mituhiro Takenoyama; Hiroshi Sumitika; Yousuke Nishimura; Kikuo Nomoto
- Publisher
- Springer-Verlag
- Year
- 1994
- Tongue
- English
- Weight
- 717 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Interleukin (ILβ) 27 is a member of ILβ12 cytokine family with Th1βpromoting and antiβinflammatory effects. ILβ27 has been shown to facilitate tumorβspecific cytotoxic T lymphocyte (CTL) induction against various tumors. However, ILβ27 suppresses cytokine production of lymphocytes and a
Thirty patients with advanced renal cell carcinoma (RCC), 23 of whom had distant metastases in at least one organ, were entered after nephrectomy into a protocol involving vaccination with Newcastle disease virus (NDV)-modified autologous tumour material, with a subsequent induction week and repetit